Breast cancer
NEW --- Systemic therapy for early stage TNBC

Lydia (51 years old)

Lydia is a 51-year-old graphic designer. She mainly creates advertisements for companies, but also draws cartoons for a local newspaper on the side. She was diagnosed with breast cancer on the right side following screening mammography.

Assessment summary

  • Premenopausal
  • Mother died of breast cancer at the age of 54
  • No relevant medical history, ECOG PS: 0
  • Tumour size: cT2 (28 mm), LN status: cN0
  • Tumour biology:
    • Ductal invasive carcinoma of NST
    • ER 0%, PgR 0%, HER2 IHC 0
    • Ki67 60%
    • G3
  • Genetic testing: BRCA1 carrier
  • CT scan chest/abdomen and bone scan: no distant metastases
  • Primary systemic therapy: 4 cycles EC dd + 12 weekly paclitaxel
  • BCS + SLNB
  • Pathology report:
    • Residual tumour: ductal invasive carcinoma of NST, ER 0%, PgR 0%, HER2/neu IHC 0, Ki67 15%
    • Stage ypT1N0
    • Residual cancer burden: RCB-II

Which of the following treatment options would you choose for this patient?